TheraPanacea
Daniel Pescia began their work experience in 2007 at Intrasense as an Ingénieur R&D. Daniel worked in this role for over 15 years until May 2022. In June 2022, they joined TheraPanacea as a Senior Software Engineer, and they currently hold this position.
Daniel Pescia's education history begins in 2002 when they entered Ecole centrale de Nantes to pursue a Diplôme d'ingénieur in Informatique. Daniel completed this degree in 2005. In 2005, they then joined CentraleSupélec to pursue a Master's degree in Ingénierie des données de la recherche médicale et biotechnologique, which they completed in 2006. Finally, they continued their education at CentraleSupélec by undertaking a Doctorat in Mathématiques appliquées from 2007 to 2010.
TheraPanacea
TheraPanacea is an innovative information technology company devoted to unlocking the power of AI-based solutions to drive innovation in healthcare. A spin-off of University Paris-Saclay, TheraPanacea works in close cooperation with the most prominent healthcare facilities to combine the power of its proprietary platforms with clinical domain-knowledge. Today, ART-Plan™, TheraPanacea dedicated suite for radio-oncology, is used by more than 60 cancer centres across Europe, Africa, Middle-East and the US and is helping to improve care for more than 60,000 patients every year. TheraPanacea also develops and operates the ART-Omics™ platform enabling pharmaceutical companies to accelerate clinical research by harnessing AI-based multi-modality biomarker discovery in clinical trials and their effective integration within the clinical workflow at scale in the form of certified medical devices.